Düsseldorf, Germany

Adelheid Degelmann

This inventor holds 1 USPTO granted patent. Top assignee: Artes Biotechnology Gmbh. Active years: 2010.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adelheid Degelmann: Innovator in Protein Production

Introduction

Adelheid Degelmann is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of biotechnology, particularly in the production of heterologous proteins using yeast-type host cells. Her innovative methods have the potential to enhance protein production processes in various applications.

Latest Patents

Adelheid holds a patent for a method of producing a heterologous protein using yeast-type host cells. This method involves preparing host cells that contain both endogenous homologous DNA sequences and recombinant DNA sequences. The recombinant sequences code for the desired protein and additional calnexins, which facilitate the secretion of the heterologous protein. The process includes inducing the host cells to express and secrete the protein, followed by the separation of the secreted product.

Career Highlights

Adelheid Degelmann is associated with Artes Biotechnology GmbH, where she applies her expertise in protein production. Her work has been instrumental in advancing biotechnological methods that can lead to more efficient production of therapeutic proteins.

Collaborations

Adelheid collaborates with notable colleagues such as Gerd Gellissen and Jens Klabunde, contributing to a dynamic research environment that fosters innovation in biotechnology.

Conclusion

Adelheid Degelmann's contributions to the field of biotechnology, particularly in the production of heterologous proteins, highlight her role as a key innovator. Her work continues to influence advancements in protein production techniques.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…